Bucher, Meghan L.
(2020)
Vesicular sequestration of dopamine modulates neuronal health in Parkinson's disease models.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
Abstract
Parkinson’s disease (PD) is the second most commonly occurring neurodegenerative disease. It is characterized by motor dysfunctions resulting from a deficiency of dopamine in the striatum caused by degeneration of dopaminergic (DAergic) neurons in the nigrostriatal pathway. While there is no cure for PD, L-DOPA is commonly prescribed to alleviate the motor symptoms by restoring dopamine in the striatum. However, L-DOPA may jeopardize the health of the remaining neurons based on evidence that dopamine handling is dysregulated in PD, which is likely the result of deficient vesicular sequestration by the vesicular monoamine transporter 2 (VMAT2). Accordingly, VMAT2 mRNA, protein, and activity are decreased in PD patients. Deficits in vesicular sequestration result in cytosolic dopamine, which is detrimental to neuronal health due to two processes – metabolism and oxidation – which generate reactive metabolites and cause oxidative stress. It is vital to investigate the consequence of impaired dopamine sequestration to understand the pathogenesis of PD and to understand how to approach therapeutic intervention in PD.
This dissertation research studied the effect of viral-mediated decreased VMAT2 expression on neuronal health. A decrease in VMAT2 resulted in increased dopamine metabolism and oxidation, deficits in dopamine-mediated behaviors, generation of aberrant α-synuclein, activation of PD-associated kinase LRRK2, and a loss of DAergic neurons in the SNpc with a corresponding degeneration of DAergic terminals in the striatum. The loss of DAergic neurons following decreased endogenous VMAT2 was rescued by reintroducing exogenous VMAT2. These data suggest that decreasing VMAT2 expression is sufficient to induce PD associated pathogenic mechanisms of neurodegeneration, further implicating the role of dysfunctional dopamine packaging in the pathogenesis of PD. Given the toxic potential of cytosolic dopamine observed, the hypothesis that increased sequestration of dopamine would be protective against nigrostriatal degeneration in a PD model was tested. While we were able to successfully demonstrate viral-mediated overexpression of VMAT2, we were unable to detect VMAT2 overexpression-mediated protection. This data is in disagreement with previous in vivo studies and is likely due to limitations of our model.
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
University of Pittsburgh ETD
|
| Status: |
Unpublished |
| Creators/Authors: |
|
| ETD Committee: |
|
| Date: |
16 January 2020 |
| Date Type: |
Publication |
| Defense Date: |
15 November 2019 |
| Approval Date: |
16 January 2020 |
| Submission Date: |
1 December 2019 |
| Access Restriction: |
1 year -- Restrict access to University of Pittsburgh for a period of 1 year. |
| Number of Pages: |
207 |
| Institution: |
University of Pittsburgh |
| Schools and Programs: |
Dietrich School of Arts and Sciences > Neuroscience |
| Degree: |
PhD - Doctor of Philosophy |
| Thesis Type: |
Doctoral Dissertation |
| Refereed: |
Yes |
| Uncontrolled Keywords: |
dopamine, neurodegeneration, Parkinson's disease |
| Date Deposited: |
16 Jan 2020 17:33 |
| Last Modified: |
16 Jan 2021 06:15 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/37838 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |
![[feed]](/images/feed-icon-32x32.png){kind=icon}